Dystroglycan induced muscular dystrophies - a review

Q-Z Zhang1

  • 1Department of Neurology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China. 386860155@qq.com.

Insights

Dystroglycanopathies, linked to α-dystroglycan O-linked glycosylation defects, cause muscular dystrophy and brain/eye abnormalities. Loss of dystroglycan in Bergmann glia underlies cognitive deficits in these muscular dystrophies.

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • Dystroglycanopathies are a group of muscular dystrophies.
  • Mutations in genes responsible for α-dystroglycan O-linked glycosylation cause these disorders.
  • Severe forms manifest with brain and ocular developmental abnormalities alongside muscular dystrophy.

Purpose of the Study:

  • To review the role of dystroglycan in cerebellar development.
  • To discuss pathological states associated with dystroglycanopathies.
  • To explore the molecular mechanisms of neuronal dysfunction in these diseases.

Main Methods:

  • Literature review of studies on dystroglycanopathies.
  • Analysis of the impact of dystroglycan loss on Bergmann glia.
  • Examination of molecular pathways involved in cognitive deficits.

Main Results:

  • Loss of dystroglycan from Bergmann glia is a primary cause of the full spectrum of developmental pathology.
  • Cognitive deficits are a consistent feature of severe dystroglycanopathies.
  • The precise molecular mechanisms of neuronal dysfunction remain incompletely understood.

Conclusions:

  • Dystroglycan plays a critical role in cerebellar development.
  • Understanding dystroglycan's function is crucial for addressing the neurological aspects of dystroglycanopathies.
  • Further research is needed to elucidate the molecular basis of neuronal dysfunction.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.5K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
5.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
705
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K